The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1606700 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Mengqi Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hangzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetic Nephropathies, Bacteria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD) exhibits heterogeneous progression, implicating factors beyond hyperglycemia, such as gut microbiota dysbiosis. However, microbial distinctions among biopsy-confirmed pure DKD, DKD with non-diabetic renal disease (DKD+NDRD), and long-term diabetes without nephropathy (DM) remain unclear. This study aimed to identify gut microbial and functional biomarkers differentiating these groups.
Methods
We enrolled 40 biopsy-confirmed participants classified into DKD (n=26), DM (n=8), and DKD+NDRD (n=6) groups. Gut microbiota was profiled using 16S rRNA sequencing. Microbial diversity, composition, and functional prediction (PICRUSt2 analysis) were compared among groups. Biomarkers were identified using LEfSe analysis.
Results
No significant differences in alpha-diversity (Chao1, Shannon indices) or beta-diversity (PCoA/PCA) were observed among groups. Taxonomic analysis revealed distinct microbial signatures: DKD patients showed enrichment of Olsenella and reduced Faecalibacterium prausnitzii (a short-chain fatty acid producer), while DM patients exhibited higher Roseburia and Flavonifractor. The DKD+NDRD group was uniquely enriched in Prevotella_9. Functional prediction highlighted elevated pyruvate metabolism and bacterial toxin pathways in DKD, contrasting with enhanced linoleic acid metabolism in DM and attenuated endotoxin-related pathways in DKD+NDRD.
Conclusions
This study delineates gut microbiota profiles and functional shifts across DKD, DM, and DKD+NDRD. Key taxa (Olsenella, Prevotella_9) and metabolic pathways (pyruvate, toxin production) may serve as biomarkers for DKD progression and differential diagnosis. The findings underscore the gut-kidney axis’s role in DKD pathogenesis and suggest microbiota-targeted interventions for precision management. Further validation in larger cohorts is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Hangzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of General Medicine, Tianshui Wulin Street Community Heal Care Centre, Hangzhou, Zhejiang, China.
- Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, Zhejiang, China.
Förderung
- Zhejiang Traditional Chinese Medicine Administration
Zitieren
APA
Wu, M., Zhou, X., Chen, S., Wang, Y., Lu, B., Zhang, A., Zhu, Y., Huang, M., Wang, J., Liu, J., Zhu, F., Liu, H., & Lin, R. (2025). The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1606700
Vancouver
Wu M, Zhou X, Chen S, Wang Y, Lu B, Zhang A, et al. The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1606700
BibTeX
@article{Wu2025,
author = {Wu, Mengqi and Zhou, Xin and Chen, Saiping and Wang, Yuqing and Lu, Bin and Zhang, Aiping and Zhu, Yanqin and Huang, Min and Wang, Jiarui and Liu, Junyi and Zhu, Fenggui and Liu, Hong and Lin, Riyang},
title = {The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1606700}
}
EUVIMED